Status:
COMPLETED
Self-sampling Among Long-term Non-attenders to Cervical Cancer Screening
Lead Sponsor:
Oslo University Hospital
Collaborating Sponsors:
University Hospital, Akershus
University of Oslo
Conditions:
Cervical Cancer
Eligibility:
FEMALE
35-69 years
Phase:
NA
Brief Summary
The trial will evaluate whether human papillomavirus (HPV) self-sampling may increase cervical cancer screening attendance among under-screened women in Norway, how different ways of offering self-sam...
Detailed Description
A randomized control trial will be performed on the effect of vaginal HPV self-sampling on screening attendance, targeting women age 35-69 who have not attended screening for at least 10 years. The wo...
Eligibility Criteria
Inclusion
- Women living in the regions Hordaland, Vest-Agder, Rogaland or Sør-Trøndelag, who have been eligible for screening in Norway, but who have not attended screening for at least 10 years (2009-2018)
Exclusion
- Women who have not been eligible for cervical cancer screening during the entire 10 year period (2009-2018)
Key Trial Info
Start Date :
March 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
5669 Patients enrolled
Trial Details
Trial ID
NCT03873376
Start Date
March 11 2019
End Date
December 30 2020
Last Update
April 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Registry of Norway
Oslo, Pb 5313 Majorstuen, Norway, 0304